Pain is common among patients with IIMs, with moderate to severe levels associated with greater fatigue, worse physical ...

Patients with rheumatic diseases less frequently receive medications to treat OUD, compared with general population estimates ...

Treatment with GUS 100 mg Q4W or Q8W led to improved joint symptoms and reduced radiographic progression vs placebo in ...

Treatment with TNF-α inhibitors may be safer than IL-6 inhibitors in terms of cardiovascular outcomes when managing patients with RA and T2D.

Perimenopause was linked to higher PsA disease activity and greater tender/swollen joint counts when compared with the pre- ...

Pregnant adolescents with SLE were more likely than healthy controls to have adverse pregnancy outcomes and more likely than ...

Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...

Upadacitinib treatment was associated with reduced non-nociceptive pain among patients with axSpA, including both neuropathic ...

Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...

Health care resource use increased in patients with Sjögren disease during the year after diagnosis, especially among those with comorbid autoimmune disorders.

Early initiation of TNF inhibitors among children with non-sJIA led to significant and sustained improvements in disease activity.

Long-term flare risk and remission rates did not differ between patients with well-controlled RA who tapered vs continued MTX therapy.